Morgan Stanley Eagle Pharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 192,213 shares of EGRX stock, worth $99,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares

192,213

Previous 300,448 36.02%

Holding current value

$99,950

Previous $1.68 Million 57.61%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.71 - $6.07 $401,551 - $656,986	-108,235 Reduced 36.02%	192,213 $713,000
Q2 2024 Oct 17, 2024	SELL	$3.34 - $5.6 $250,102 - $419,333	-74,881 Reduced 19.95%	300,448 $1.68 Million
Q2 2024 Aug 14, 2024	SELL	$3.34 - $5.6 $250,102 - $419,333	-74,881 Reduced 19.95%	300,448 $1.68 Million
Q1 2024 Oct 17, 2024	BUY	$4.26 - $6.51 $318,993 - $487,475	74,881 Added 24.92%	375,329 $1.97 Million
Q1 2024 Aug 16, 2024	BUY	$4.26 - $6.51 $334,260 - $510,807	78,465 Added 26.43%	375,329 $1.97 Million
Q1 2024 May 15, 2024	BUY	$4.26 - $6.51 $334,260 - $510,807	78,465 Added 26.43%	375,329 $1.97 Million
Q4 2023 Aug 16, 2024	SELL	$4.63 - $15.21 $16,593 - $54,512	-3,584 Reduced 1.19%	296,864 $1.55 Million
Q4 2023 Feb 13, 2024	BUY	$4.63 - $15.21 $614,813 - $2.02 Million	132,789 Added 80.93%	296,864 $1.55 Million
Q3 2023 Nov 15, 2023	SELL	$15.21 - $22.88 $273,323 - $411,153	-17,970 Reduced 9.87%	164,075 $2.59 Million
Q2 2023 Aug 14, 2023	SELL	$17.74 - $31.87 $1.13 Million - $2.03 Million	-63,765 Reduced 25.94%	182,045 $3.54 Million
Q1 2023 May 15, 2023	SELL	$25.06 - $34.09 $111,968 - $152,314	-4,468 Reduced 1.79%	245,810 $6.97 Million
Q4 2022 Feb 14, 2023	BUY	$24.98 - $39.77 $456,809 - $727,273	18,287 Added 7.88%	250,278 $7.32 Million
Q3 2022 Nov 14, 2022	BUY	$26.42 - $47.12 $519,998 - $927,415	19,682 Added 9.27%	231,991 $6.13 Million
Q2 2022 Oct 27, 2022	BUY	$41.26 - $51.35 $2.68 Million - $3.34 Million	65,014 Added 44.14%	212,309 $9.43 Million
Q2 2022 Aug 15, 2022	BUY	$41.26 - $51.35 $2.68 Million - $3.34 Million	65,014 Added 44.14%	212,309 $9.43 Million
Q1 2022 Oct 27, 2022	SELL	$44.58 - $52.6 $2.9 Million - $3.42 Million	-65,014 Reduced 30.62%	147,295 $7.29 Million
Q1 2022 May 13, 2022	BUY	$44.58 - $52.6 $664,643 - $784,213	14,909 Added 11.26%	147,295 $7.29 Million
Q4 2021 Feb 14, 2022	SELL	$45.82 - $56.9 $747,370 - $928,095	-16,311 Reduced 10.97%	132,386 $6.74 Million
Q3 2021 Nov 15, 2021	BUY	$43.79 - $55.78 $6.51 Million - $8.29 Million	148,697 New	148,697 $8.29 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $6.77M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account